Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye disease with innovative small molecules to preserve, slow, or restore vision loss.

View Executive Team

Latest Financial Results

Q2 2025

Quarter Ended Jun 30, 2025

View All Financial Results

Earnings Release

10-Q XBRL Zip

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

View 10-K

IR Contacts

Headquarters

Kiora Pharmaceuticals, Inc.
169 Saxony Rd
Suite 212
Encinitas, CA 92024

Investor Relations

investors@kiorapharma.com

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Latest News

Email Alerts

Latest Presentation

Recent Event

Company Overview